Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II

OBJECTIVE: Our objective was to determine if treatment with cyclophosphamide (CYC) and mycophenolate mofetil (MMF) improves patient‐reported outcomes (PROs) among patients with systemic sclerosis‐related interstitial lung disease (SSc‐ILD). METHODS: This study examined PROs in patients with SSc‐ILD...

Descripción completa

Detalles Bibliográficos
Autores principales: Volkmann, Elizabeth R., Tashkin, Donald P., LeClair, Holly, Roth, Michael D., Kim, Grace, Goldin, Jonathan, Clements, Philip J., Furst, Daniel E., Khanna, Dinesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301868/
https://www.ncbi.nlm.nih.gov/pubmed/32432411
http://dx.doi.org/10.1002/acr2.11125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301868/
https://www.ncbi.nlm.nih.gov/pubmed/32432411
http://dx.doi.org/10.1002/acr2.11125

Ejemplares similares